「us」の検索結果
76件：66～70件目を表示
-
研究開発の取り組み | 千寿製薬株式会社
evelopment System R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licensing★senju.co.jp* When contacting us by e-mail, please change &...
http://www.senju.co.jp/english/rd/ -
CEO Message | About Senju | SENJU Pharmaceutical
, we have been making efforts for more than 70 years to develop excellent medicines and services focusing on the ophthalmology field through our unique ideas and R&D capabilities.Throughout our hi...
https://www.senju.co.jp/english/about/message.html -
aceutical Co., Ltd. Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation cha...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf -
aceutical Co., Ltd. Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation cha...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
Product Development Policy | Research & Development | SENJU Pharmaceutica
ucoma, ocular hypertension, etc. We also contributed to reducing the economic burden on patients by using various generic drugs and biosimilars. In addition, there are various other eye diseases. The ...
http://www.senju.co.jp/english/rd/policy/